In early March, Kenya procured over 1 million doses of Oxford-AstraZeneca vaccine doses through the COVID-19 Vaccines Global Access initiative, a World Health Organization-backed global vaccine distribution effort known as COVAX.
Mapema mwezi Machi, Kenya ilinunua zaidi ya dozi milioni 1 za chanjo ya Oxford-AstraZeneca kupitia mpango wa Upatikanaji wa Chanjo ya UVIKO-19 Duniani, inayoratibiwa na Shirika la Afya Duniani kupitia utaratibu unaoitwa COVAX.